ENTRY       D11265                      Drug
NAME        Taldefgrobep alfa (USAN/INN);
            Talditercept alfa (USAN)
FORMULA     C3386H5242N882O1048S16
EXACT_MASS  75539.9537
MOL_WEIGHT  75586.1723
SEQUENCE    DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
            GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
            GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
            DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPELQLE ESAAEAQEGE
            LEGVSDVPRD LEVVAATPTS LLISWTLPHA GRAHYYRITY GETGGNSPVQ EFTVPGRGVT
            ATISGLKPGV DYTITVYAVT VTTTKVIHYK PISINYRTEI
            (Disulfide bridge: 6-6', 9-9', 41-101, 41'-101', 147-205, 147'-205')
  TYPE      Peptide
EFFICACY    Myostatin inhibitor
COMMENT     Treatment of ALS, Duchenne muscular dystrophy and spinal muscular atrophy
TARGET      MSTN [HSA:2660] [KO:K05497]
  PATHWAY   hsa04060(2660)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Transforming growth factors (RSTK-binding)
                MSTN
                 D11265  Taldefgrobep alfa (USAN/INN)
DBLINKS     CAS: 1580555-26-5
            PubChem: 384585243
///
